FSLR Unusual Options Activity — 2026-03-30

☀️ FSLR $7.2M LEAP Call - Someone Is Making a 22-Month Solar Mega-Bet!

📅 March 30, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

Someone just dropped $7.2 MILLION on First Solar January 2028 $270 calls - a 22-month bet that needs FSLR to surge 44% from current levels just to break even. This is a fully new position (Vol/OI at 51x!) timed right as the ITC's TOPCon investigation formally launched, the stock sits 35% off its highs, and the next earnings report is just 24 days away. A whale is loading up a deep out-of-the-money LEAP while the solar sector is under maximum fear - and that deserves your full attention.

---

📊 Company Overview

First Solar (FSLR) is America's dominant solar manufacturer and the only major CdTe thin-film producer at scale:

• ☀️ What they do: Manufactures cadmium telluride (CdTe) thin-film photovoltaic solar modules for utility-scale power plants
• 💰 Market Cap: $20.4B
• 🏢 Sector: Solar Energy Manufacturing (SIC: Semiconductors & Related Devices)
• 📈 Exchange: NASDAQ
• 📊 Current Price: $187.55
• 🏭 Key Story: America's only major domestic solar manufacturer with 14 GW U.S. nameplate capacity, fully immune to import tariffs and FEOC restrictions - and right now suing 47 overseas competitors in a patent case that could reshape the entire U.S. solar market

---

💰 The Option Flow Breakdown

📊 The Tape

🤓 What This Actually Means

Let me break this down in plain English:

• 💸 $7.2 million committed: 2,050 contracts at $35.35 each ($35.35 x 100 x 2,050 = ~$7.25M)
• 📈 Strike $270 is 44% above the current price of $187.55 - this is a deep out-of-the-money bet requiring a serious bull run
• ⏰ 22 months to expiration (January 21, 2028) - this is a LEAP of the longest variety, giving maximum time for the solar story to unfold
• 📊 Vol/OI ratio = 51x - volume blew out open interest of just 41 contracts by 51 times, confirming this is a fresh Buy-to-Open position with zero prior institutional presence at this strike
• 🤝 MID fill - executed at the midpoint of the bid-ask spread, the institutional signature move (retail traders hit the ask)
• 🎯 Breakeven at expiration: $305.35 ($270 strike + $35.35 premium paid) = needs a +62.8% rally from current levels

What's the thesis here?

This trader has 22 months to be right, and they're paying $35.35 per share for the privilege. That's roughly 18.8% of the stock price. Why do it? Because FSLR is trading at levels last seen before its big 2024-2025 run, the fundamentals around domestic manufacturing are structurally improving, and a potential ITC general exclusion order against TOPCon competitors could turn First Solar into the only viable large-scale solar supplier in the U.S. market.

The $270 strike sits above every current analyst price target except Guggenheim's $269. This trader is not playing for a modest recovery - they are betting on a full re-rating of the stock back to or above its 52-week highs.

Why a 51x Vol/OI signal matters so much here:

This strike had essentially no open interest - just 41 contracts. Someone came in cold with 2,050 contracts and owns 98% of this position. This is not rolling an existing trade. This is fresh conviction money opening a brand-new directional bet from scratch.

---

📈 Technical Setup / Chart Check-Up

YTD Performance

FSLR has had a brutal 2026 so far. The stock entered the year around $250+ and got crushed after Q4 2025 earnings on February 25 triggered an 18% single-day drop when FY2026 guidance came in nearly $1B below Wall Street expectations. From there the stock has continued sliding to the $183-$188 range, roughly 35% below its 52-week highs.

Key chart observations:

• 📉 YTD decline: Down roughly 25-30% year-to-date with no meaningful recovery bounce yet
• 🔴 Below key moving averages: Trading well below both the 50-day and 200-day moving averages since February
• 📊 Support test: The $183-$185 area has held on multiple closes - this is the current base
• 📈 Volume: Elevated institutional volume during the February selloff; current volume normalizing
• 🎯 The setup: Oversold, hated, and sitting near multi-year support - exactly where contrarian LEAP buyers like to enter

Gamma-Based Support & Resistance Analysis

Current Price: $184.36 (at time of GEX calculation)

The gamma exposure map shows where market makers have concentrated options positions, creating real magnetic price levels:

🔵 Support Levels (Put Gamma Below Price):

• $180 - Strongest immediate support with 2.06B gamma exposure (immediate floor, just 2.2% below current price)
• $175 - Secondary support at 0.85B gamma (5% below)
• $170 - Solid structural support at 1.05B gamma (8% below - key range floor)
• $160 - Deep support at 1.03B gamma (13% below)
• $150 - Extended floor at 1.02B gamma (disaster scenario level)

🟠 Resistance Levels (Call Gamma Above Price):

• $190 - First overhead resistance at 1.34B gamma (just 3% above - first hurdle)
• $195 - Secondary resistance at 0.92B gamma (5.7% above)
• $200 - Major psychological resistance at 1.32B gamma (8.5% above - the key breakout level)
• $210 - Extended resistance at 1.17B gamma (13.9% above)
• $220 - Far resistance at 0.85B gamma (19.3% above)

Net GEX Bias: Bullish - dealer positioning leans bullish, supporting the thesis that the $180 floor is a real level. A hold above $180 keeps the structure intact for a bounce.

What this means: FSLR is sandwiched between $180 support and $190 resistance. The $200 level is the critical line - a clean reclaim of $200 changes the technical picture from "recovery attempt" to "confirmed reversal." The $270 LEAP strike sits far above all current gamma levels, which is consistent with a 22-month bet rather than a short-term swing.

Implied Move Analysis

Options market pricing for upcoming expirations:

• 📅 Monthly OPEX - April 17, 2026 (18 days): ±$15.72 (±8.57%) → Range: $167.79 - $199.24

Translation for the $270 LEAP:

The April OPEX implies FSLR could swing 8.57% over the next 18 days - that's a meaningful move around Q1 earnings (April 23 is just after OPEX). The upper implied range of $199.24 aligns almost exactly with the $200 gamma resistance, confirming that $200 is the pivotal near-term level. The lower bound of $167.79 shows the market is genuinely pricing in downside risk to $168.

For the January 2028 LEAP, the 22-month implied distribution is massive - the options market sees FSLR potentially anywhere from the $100s to well above $300 by expiration. The $305.35 breakeven is achievable within the upper tail of that distribution, which is why this bet exists.

---

🎪 Catalysts

🔥 Upcoming Catalysts

Q1 2026 Earnings - April 23, 2026 (after close) 📊

The next big inflection point. The Street expects EPS of $3.06 non-GAAP and revenue around $1.06B. The most critical number to watch will NOT be earnings - it's net new bookings. If management shows quarterly bookings inflecting back above 2-3 GW, the thesis that the guidance miss was temporary gets meaningful support. Any guidance revision upward or commentary on ITC progress could spark a sharp rally.

ITC TOPCon Investigation - Preliminary Ruling Expected Mid-to-Late 2027 ⚖️

This is the single most asymmetric catalyst in the entire solar sector. The ITC formally instituted the investigation on March 25-26, 2026, naming 47 entities including JinkoSolar, Canadian Solar, JA Solar, Trina Solar, and Hanwha Q Cells. If a general exclusion order is granted, it would block essentially all competing TOPCon cells from entering the U.S., leaving First Solar's CdTe technology as the dominant U.S. solar supply option. This is a 12-18 month process, but any interim developments - discovery milestones, settlements, licensing deals - could create near-term catalysts well before the final ruling.

South Carolina Factory Commissioning - H2 2026 🏭

A $330M facility in Gaffney, Cherokee County with 3.7 GW annual capacity and 600 new jobs. This brings U.S. nameplate capacity to 17.7 GW by 2027, cementing the domestic manufacturing moat that makes FSLR uniquely positioned among solar companies.

Q2 2026 Earnings - Expected Late July 2026 📊

First quarter where South Carolina ramp progress and any ITC interim developments will be discussed. Full-year guidance update likely. This is the "show me" quarter for booking recovery.

45X Tax Credit Dynamics 💰

FY2026 guidance includes $2.1B-$2.19B in Section 45X manufacturing production tax credits - roughly 40%+ of guided revenue. Any legislative clarity extending these credits beyond their current 2026 integrated component expiration date would be a significant positive catalyst.

Federal Permitting Reform 🏗️

The current permitting freeze on federal land has pushed ~30% of expected 2026-2027 solar capacity into later years. Any bipartisan permitting reform would directly accelerate the project pipeline feeding First Solar's backlog.

✅ Recent Catalysts (Already Happened)

ITC Investigation Formally Instituted - March 25-26, 2026 ⚖️

The U.S. Patent and Trademark Office previously validated First Solar's TOPCon IP in January 2026, denying three separate inter partes review petitions from JinkoSolar, Canadian Solar, and Mundra Solar. Now the ITC has launched the formal investigation. These two sequential wins establish a strong foundation for the lawsuit.

Q4 2025 Earnings - February 24, 2026 📊

Revenue of $1.68B (+11.1% YoY) beat consensus by 7%, but FY2026 guidance of $4.9B-$5.2B came in nearly $1B below the $6.16B Wall Street consensus, triggering the 18% single-day crash. Full-year 2025 was actually a record at $5.2B in revenue and $14.21 diluted EPS.

Oxford PV Licensing Agreement - February 25, 2026 🔬

First Solar and Oxford PV entered a licensing agreement to advance perovskite freedom-to-operate, signaling strategic positioning in next-generation tandem solar cell technology.

Section 201 Tariff Expiration - February 6, 2026 🌐

Broad Section 201 safeguard tariffs expired, but additional tariffs on Cambodia, Malaysia, Thailand, and Vietnam remain with subsidy rates as high as 3,403.96% on some exporters. This maintains the cost disadvantage for imported Chinese-origin modules.

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, analyst consensus, and the catalyst calendar through the January 2028 expiration:

📈 Bull Case (25% probability)

Target: $270-$330+

How we get there:

• 🏆 ITC grants a general exclusion order on TOPCon imports (transformative competitive moat)
• 📊 Q1 and Q2 earnings show bookings recovery - backlog starts growing again
• 🏭 South Carolina ramp executes on schedule, pushing U.S. capacity to 17.7 GW
• 💡 45X tax credit extended legislatively beyond 2026
• ⚡ Data center power demand explodes - data center electricity demand could double, driving hyperscaler multi-GW solar PPAs directly to FSLR
• 📈 Stock reclaims $200, $210, $220 gamma resistance levels in sequence, consensus PT lifts toward $270+

LEAP trade P&L at $305: Calls worth ~$35/share at expiration, roughly break-even on premium. Any higher and it's pure profit. LEAP trade P&L at $330: Calls worth ~$60/share, net gain = ~$24.65 x 2,050 contracts = ~$5.05M gain (70% ROI)

🎯 Base Case (45% probability)

Target: $220-$260 by January 2028

Most likely scenario:

• ✅ ITC investigation proceeds without early resolution - remains an option value story
• 📊 Q1 earnings meet low bar, bookings begin modest recovery through mid-2026
• 🏭 South Carolina ramp on track, facility commissioning on schedule in H2 2026
• ⚖️ Analyst consensus around $243.85 average PT acts as medium-term magnet
• 📈 Stock grinds through $190, $200, $210 resistance over the next 9-12 months

LEAP trade P&L at $250: Calls expire worthless (below $270 strike), loss = -$7.2M (-100%)

However, if the stock reaches $250 with 6+ months remaining before January 2028, there is still substantial time value in these calls (likely $15-25 each). A patient trader could still capture a meaningful partial recovery at $250 with extrinsic value intact.

📉 Bear Case (30% probability)

Target: $150-$185 range

What could go wrong:

• 😰 ITC complaint fails or is settled on unfavorable terms, TOPCon imports continue unabated
• 🚨 45X integrated component tax credit eliminated or capped - $2.1B revenue hole opens up
• 📉 Bookings continue declining, backlog falls below 45 GW, guidance cut again at Q1 earnings
• 💸 Federal permitting freeze extended through 2027, large utility-scale projects pushed into 2028+
• 🔴 Break below $180 gamma support triggers cascade toward $160 and potentially $150
• 📊 Broader solar sector de-rating as interest rates stay elevated, project economics deteriorate

LEAP trade P&L: Calls expire worthless, loss = -$7.2M (-100%)

The $180 gamma support is the critical technical line. A weekly close below $180 would meaningfully invalidate the near-term recovery thesis.

---

💡 Trading Ideas

🛡️ Conservative: "Piggyback the ITC Story" - Debit Call Spread

Play: Buy FSLR January 2028 $200 calls, sell FSLR January 2028 $250 calls

Why this works:

• 📊 Same 22-month LEAP timeframe as the whale trade but with dramatically lower cost
• 🛡️ The $200 strike is only 6.6% above current price - much more achievable than $270
• 💰 Max profit: $50 per spread minus the net debit paid (roughly $25-30 debit = $20-25 gain)
• ⏰ Captures the same ITC/earnings/SC ramp catalyst window with defined risk
• 📈 A move to $250 - still below the analyst consensus average of $243.85 - puts you at maximum profit

Position sizing: Risk 3-5% of portfolio. 5 spreads at ~$27 each = ~$13,500 risk for ~$10,000-$11,500 max gain.

Risk level: Moderate (defined risk) | Skill level: Intermediate

⚖️ Balanced: "Earnings Bounce Play" - April/May Call Diagonal

Play: Buy FSLR June 2026 $200 calls, sell FSLR April 17, 2026 $195 calls against them (poor man's covered call)

Why this works:

• 🎯 Targets the near-term earnings catalyst on April 23 while staying defined-risk
• 💸 Selling the April $195 call collects premium to reduce your cost basis on the June $200
• 📊 If FSLR bounces to $195-200 into/after earnings, the short April leg expires and you own the June $200 call outright at a reduced cost
• ⏰ Rolling short legs each month can further reduce cost basis if stock stays rangebound
• 📈 The implied move of ±8.57% for April OPEX supports $195-$199 as a realistic rally target

Position sizing: 10 spreads at $8-12 net debit = ~$10,000 risk.

Risk level: Moderate | Skill level: Intermediate-Advanced

🚀 Aggressive: "Full Send the ITC Thesis" - Jan 2028 $240 Calls

Play: Buy FSLR January 21, 2028 $240 calls outright

Why this works (and why it's risky):

• 💥 Lower strike ($240 vs $270) means higher delta - more immediately responsive to price moves
• 📊 $240 still aligns with the upper end of analyst price targets (Guggenheim $269, Barclays $228, RBC $236)
• ⏰ Same 22-month timeframe captures all major catalysts: four earnings reports, ITC milestones, SC ramp, permitting reform
• 🚀 If FSLR reaches $280-$300 by expiration, these calls could triple from your entry price
• 🤝 Following the institutional thesis at a $30 lower strike gives you more margin for error

Why it could blow up:

• 💸 Still paying significant premium (~$45-50 per contract) for a deep OTM call
• ⏰ 22 months of theta decay is real - requires FSLR to keep moving toward the target
• 📉 If FSLR stays below $240, you lose the full premium
• 🎢 A second guidance miss at Q1 earnings could push the stock toward the $160-$170 range

Position sizing: Risk ONLY what you can afford to lose completely. 5 contracts = ~$22,500-$25,000 at risk.

Risk level: HIGH (can lose 100% of premium) | Skill level: Advanced

---

⚠️ Risk Factors

Don't ignore these potential landmines:

• 📉 Strike is 44% OTM: The $270 strike requires FSLR to stage one of its biggest multi-year rallies from a depressed base. Even with 22 months of runway, FSLR needs to break through $190, $200, $210, $220 gamma resistance levels AND reclaim the post-earnings crash territory above $250. That's a lot of work.

• 📊 Backlog is depleting: FSLR entered 2026 with 50.1 GW of backlog valued at $15B, down from 53.7 GW at the end of Q3 2025. Net debookings of 0.9 GW occurred in FY2025. If bookings don't recover meaningfully, the revenue outlook deteriorates further regardless of manufacturing capacity.

• 💸 45X credit cliff in December 2026: First Solar's FY2026 guidance bakes in $2.1B-$2.19B of Section 45X credits - roughly 40%+ of guided revenue. The integrated component credit expires December 31, 2026. Any legislative failure to extend means a massive revenue hole opens in 2027 just as the LEAP approaches expiration.

• ⚖️ ITC case is 12-18 months away: The investigation was just instituted. A preliminary ruling is not expected until mid-to-late 2027. The stock likely won't fully price in an exclusion order until there's a ruling in hand. This removes the most powerful catalyst from the near-term window.

• 🧑‍💼 Clustered insider selling: Multiple C-suite executives including CEO Mark Widmar sold shares on March 9-10, 2026. Institutional ownership at 92.08% amplifies every price move. When insiders sell at prices between $190-$196 and the stock is now at $187, it signals management sees limited near-term upside.

• 🌍 Federal permitting freeze impact: The current freeze on federal land permits for utility-scale solar has removed an estimated 30% of expected 2026-2027 solar capacity from the near-term pipeline. This directly reduces demand for First Solar's modules regardless of how good their manufacturing position is.

• 🏭 SE Asia underutilization costs: First Solar is idling Malaysia and Vietnam factories to ~20% capacity utilization and absorbing ~$155M in underutilization charges in 2026. This is cash out the door with no revenue return, compressing margins during an already weak guidance period.

• 💻 Technology efficiency gap: CdTe modules top out at 19.9% efficiency vs TOPCon's 24.9%. Even if FSLR wins the ITC case, customers needing higher efficiency per square foot (like rooftop solar or constrained sites) still prefer silicon. The domestic manufacturing moat applies mainly to utility-scale projects.

---

🎯 The Bottom Line

Real talk: Someone just put $7.2 million into a bet that First Solar is going to $270 or higher by January 2028. That's not a hedge - it's a pure directional conviction play on the entire domestic solar thesis. They chose the longest LEAP available, a strike well above every analyst price target, and opened a completely fresh position on a day when the ITC investigation just formally launched and the stock is sitting 35% off its highs.

What this trade tells us:

• 🎯 The whale believes the ITC TOPCon case is far more valuable than the market currently prices in - a general exclusion order would be transformative
• 🏭 They see the domestic manufacturing buildout (South Carolina, Louisiana, Ohio) as a structural moat that compounds over the next two years
• ⚡ The AI-driven data center power demand surge creates a multi-year utility-scale solar demand wave that FSLR is uniquely positioned to capture as the only major domestic manufacturer
• 📊 The 51x Vol/OI confirms this is fresh, high-conviction capital - not a hedge or a roll

This IS a significant bullish signal - but with important context:

FSLR is a legitimate "I'm willing to be wrong for a year before being right" trade. The near-term picture is genuinely messy: the guidance miss was real, bookings are declining, insider selling is happening, and the ITC resolution is 12-18 months away. But the 22-month window is exactly what a patient investor needs to let the catalysts play out.

If you're bullish on FSLR:

• ✅ Consider the bull call spread approach ($200/$250 Jan 2028) rather than naked calls to reduce cost while maintaining upside
• 📊 The $180 gamma support is your near-term floor - a weekly close below that level changes the thesis
• ⏰ Mark April 23 (Q1 earnings) as your first major checkpoint - bookings trajectory is the number to watch
• 💡 The ITC case is a slow-burn catalyst but interim developments (settlement talks, discovery) can move the stock well before the final ruling

If you're watching from the sidelines:

• 🎯 A flush to the $167-$170 implied move support level (lower bound of April OPEX implied range) would offer a more attractive entry
• 📊 Wait for April 23 earnings to confirm or deny the bookings recovery thesis before committing
• 📈 The analyst consensus average target of $243.85 with Guggenheim at $269 shows the Street sees 30%+ upside from here - even without the ITC wildcard

If you're cautious:

• ⚠️ The 45X credit cliff (December 2026) and the backlog depletion trend are real structural risks
• 📉 A second guidance cut at Q1 earnings - particularly if bookings are still trending negative - could push FSLR toward $160 and make even the $200 strike look ambitious
• 🛡️ If you own shares, consider a collar (buy a put spread below $180, sell a call at $210-$220) to protect your position through the earnings event

Key dates to mark:

• 📅 April 17, 2026 - Monthly OPEX (implied range: $167.79 - $199.24)
• 📅 April 23, 2026 - Q1 2026 earnings (after close) - THE near-term binary event
• 📅 H2 2026 - South Carolina factory commissioning (3.7 GW capacity addition)
• 📅 Late July 2026 - Q2 2026 earnings (bookings recovery trajectory)
• 📅 December 31, 2026 - 45X integrated component credit deadline (legislative wildcard)
• 📅 Mid-to-Late 2027 - ITC preliminary ruling on TOPCon investigation
• 📅 January 21, 2028 - THIS TRADE EXPIRES - moment of truth for the $7.2M bet

Final verdict: First Solar's domestic manufacturing position is genuinely rare - no other large-scale solar manufacturer in the U.S. has FSLR's combination of FEOC compliance, tariff immunity, and manufacturing scale. The ITC case, if successful, could turn that into a near-monopoly. The question is whether 22 months is enough time for all those dominoes to fall. The whale thinks yes. The stock at $187 - 35% off highs with a fresh $7.2M LEAP bet opened at a 51x unusual volume ratio - deserves a spot on your watchlist at minimum.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and is not financial advice. Past performance does not guarantee future results. LEAP calls are high-risk instruments that can lose 100% of the premium paid if the underlying stock does not reach the strike price by expiration. Options involving deep out-of-the-money strikes and long-dated expirations involve significant time decay and volatility risk. Always conduct your own research and consult a licensed financial advisor before making any investment decisions.

---

About First Solar: First Solar is the sole large-scale CdTe thin-film photovoltaic manufacturer globally and the largest U.S. domestic solar manufacturer, with 14 GW of U.S. nameplate capacity and a $20.4B market cap listed on NASDAQ. The company operates facilities in Ohio, Alabama, Louisiana, and the newly commissioning South Carolina plant, generating record revenue of $5.2B in FY2025.